These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6489614)

  • 1. Immunogenic properties on mice of cell-wall-deficient Brucella (L-forms).
    Schmitt-Slomska J; Caravano R; Starka G; Mauss H; Drach G; Lemaire J
    Dev Biol Stand; 1984; 56():187-97. PubMed ID: 6489614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on Brucella-L-forms. II. Serological properties of Brucella-L-forms].
    Peschkov J
    Zentralbl Bakteriol Orig A; 1971 Dec; 218(4):437-43. PubMed ID: 4400725
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of Bacillus megaterium H on the immune response to heterologous antigen in mice].
    Zatula DG; Lisovenko GS; Siadro TA
    Mikrobiol Zh (1978); 1986; 48(1):77-81. PubMed ID: 3151913
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitization of guinea pigs with L and S forms of Proteus mirabilis D52].
    Toshkov A; Kenarova B; Ivanova E; Gumpert I
    Acta Microbiol Bulg; 1982; 11():86-90. PubMed ID: 6763463
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of murine bone marrow colony formation and L-transformation by Brucella antigen.
    Elberg SS; Ralston DJ
    Can J Comp Med; 1980 Jul; 44(3):320-7. PubMed ID: 6775795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenic properties of the cellular components of Brucella].
    Baeva AA; Taran IF
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):71-6. PubMed ID: 812309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antigenic structure of the L forms of Br. Abortus 544].
    Peshkov I
    Vet Med Nauki; 1979; 16(2):52-9. PubMed ID: 92852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the toxic, antigenic and sensitizing properties of preparations isolated from the cell wall of Brucella].
    Vershilova PA; Chernysheva MI; Dranovskaia EA
    Biull Eksp Biol Med; 1971 Jun; 71(6):62-4. PubMed ID: 5097385
    [No Abstract]   [Full Text] [Related]  

  • 9. Properties of cell wall antigens of virulent Brucella canis and a less mucoid variant of reduced pathogenicity.
    Zoha SJ; Carmichael LE
    Am J Vet Res; 1982 Jan; 43(1):171-4. PubMed ID: 6807143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed type hypersensitivity to mycobacterial antigens without protective immunity: a failure to produce the right specificity or the right type of immune reaction?
    Løvik M; Closs O
    Scand J Infect Dis Suppl; 1980; Suppl 24():224-7. PubMed ID: 7010561
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell antigen recognition.
    Perry LL; Greene MI
    J Immunol; 1980 Aug; 125(2):738-48. PubMed ID: 6967088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sensitizing properties of Brucella protein antigens synthesized in K12 Escherichia coli cells].
    Malikov VE; Seliutina DF; Gorelov VN; Chibisova VA; Dranovskaia EA
    Mol Gen Mikrobiol Virusol; 1991 Jul; (7):29-32. PubMed ID: 1745265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experimental myocarditis of mice immunized with group A streptococcal cytoplasmic membrane fraction extracted from L-forms.
    Matsunaga K; Katoh K; Takahashi T; Sakamoto H; Tani K; Okuda K; Tadokoro I; Kitamura H
    Jpn J Exp Med; 1982 Oct; 52(5):267-70. PubMed ID: 6763085
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic and immunogenic properties of the pili and external wall of the gonococcus].
    Ovchinnikov NM; Delektorskiĭ VV; Timchenko GF; Dmitriev GA
    Vestn Dermatol Venerol; 1981 Jul; (7):11-5. PubMed ID: 6117164
    [No Abstract]   [Full Text] [Related]  

  • 16. [Attempts of ultrastructural and biochemical characterisation of cell wall deficient "Brucella" (L forms) (author's transl)].
    Schmitt-Slomska J; Caravano R; Thomas P; Roux J
    Ann Microbiol (Paris); 1982; 133(3):377-86. PubMed ID: 7103308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological characteristics of the cellular components of Brucellae].
    Shin NG; Rementsova MM; Studentsova VK; Tsirel'son LE; Tsoĭ VP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):92-6. PubMed ID: 6524172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of L-forms from the spleens of Brucella suis-infected, penicillin-treated mice.
    Schmitt-Slomska J; Caravano R; Anoal M; Gay B; Roux J
    Ann Microbiol (Paris); 1981; 132(3):253-65. PubMed ID: 7294609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Problems in the serodiagnosis of canine brucellosis: dog responses to cell wall and internal antigens of Brucella canis.
    Carmichael LE; Zoha SJ; Flores-Castro R
    Dev Biol Stand; 1984; 56():371-83. PubMed ID: 6489621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.